Johnson Investment Counsel’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.03M | Buy |
12,976
+87
| +0.7% | +$13K | 0.01% | 341 |
|
|
2026
Q1 | $1.97M | Sell |
12,889
-2,077
| -14% | -$318K | 0.02% | 330 |
|
|
2025
Q4 | $2.06M | Hold |
14,966
| – | – | 0.02% | 308 |
|
|
2025
Q3 | $1.92M | Sell |
14,966
-3,740
| -20% | -$456K | 0.02% | 316 |
|
|
2025
Q2 | $2.26M | Sell |
18,706
-400
| -2% | -$45.1K | 0.02% | 281 |
|
|
2025
Q1 | $2.13M | Buy |
19,106
+816
| +4% | +$86.9K | 0.02% | 283 |
|
|
2024
Q4 | $1.78M | Sell |
18,290
-250
| -1% | -$26.7K | 0.02% | 307 |
|
|
2024
Q3 | $2.13M | Sell |
18,540
-664
| -3% | -$75.3K | 0.02% | 277 |
|
|
2024
Q2 | $2.04M | Buy |
19,204
+122
| +0.6% | +$12.2K | 0.02% | 270 |
|
|
2024
Q1 | $1.85M | Buy |
19,082
+387
| +2% | +$39.7K | 0.02% | 287 |
|
|
2023
Q4 | $1.89M | Buy |
18,695
+1,412
| +8% | +$136K | 0.02% | 263 |
|
|
2023
Q3 | $1.76M | Buy |
17,283
+1,030
| +6% | +$105K | 0.02% | 264 |
|
|
2023
Q2 | $1.64M | Buy |
16,253
+37
| +0.2% | +$3.7K | 0.02% | 276 |
|
|
2023
Q1 | $1.49M | Sell |
16,216
-345
| -2% | -$30.1K | 0.02% | 289 |
|
|
2022
Q4 | $1.5M | Buy |
16,561
+2,865
| +21% | +$241K | 0.02% | 286 |
|
|
2022
Q3 | $1.04M | Buy |
13,696
+226
| +2% | +$18.7K | 0.02% | 319 |
|
|
2022
Q2 | $1.14M | Buy |
13,470
+192
| +1% | +$16.8K | 0.02% | 303 |
|
|
2022
Q1 | $1.17M | Sell |
13,278
-487
| -4% | -$42.2K | 0.01% | 325 |
|
|
2021
Q4 | $1.2M | Buy |
13,765
+12
| +0.1% | +$996 | 0.01% | 326 |
|
|
2021
Q3 | $1.13M | Sell |
13,753
-105
| -0.8% | -$9.45K | 0.02% | 326 |
|
|
2021
Q2 | $1.26M | Sell |
13,858
-33
| -0.2% | -$2.94K | 0.02% | 294 |
|
|
2021
Q1 | $1.19M | Sell |
13,891
-170
| -1% | -$15.3K | 0.02% | 288 |
|
|
2020
Q4 | $1.33M | Buy |
14,061
+383
| +3% | +$33.5K | 0.02% | 257 |
|
|
2020
Q3 | $1.19M | Sell |
13,678
-96
| -0.7% | -$8.32K | 0.02% | 253 |
|
|
2020
Q2 | $1.2M | Sell |
13,774
-143
| -1% | -$12.3K | 0.02% | 242 |
|
|
2020
Q1 | $1.15M | Sell |
13,917
-1,226
| -8% | -$109K | 0.03% | 225 |
|
|
2019
Q4 | $1.43M | Buy |
15,143
+297
| +2% | +$26.6K | 0.03% | 242 |
|
|
2019
Q3 | $1.29M | Sell |
14,846
-994
| -6% | -$89.2K | 0.03% | 251 |
|
|
2019
Q2 | $1.45M | Sell |
15,840
-2,133
| -12% | -$181K | 0.03% | 245 |
|
|
2019
Q1 | $1.55M | Sell |
17,973
-2,224
| -11% | -$179K | 0.03% | 235 |
|
|
2018
Q4 | $1.55M | Buy |
20,197
+1,657
| +9% | +$129K | 0.04% | 222 |
|
|
2018
Q3 | $1.43M | Buy |
18,540
+9
| +0% | +$665 | 0.03% | 255 |
|
|
2018
Q2 | $1.25M | Sell |
18,531
-4,920
| -21% | -$340K | 0.03% | 265 |
|
|
2018
Q1 | $1.7M | Sell |
23,451
-465
| -2% | -$35.4K | 0.04% | 192 |
|
|
2017
Q4 | $1.8M | Buy |
23,916
+1,653
| +7% | +$125K | 0.04% | 196 |
|
|
2017
Q3 | $1.71M | Sell |
22,263
-30
| -0.1% | -$2.27K | 0.05% | 186 |
|
|
2017
Q2 | $1.67M | Buy |
22,293
+1,947
| +10% | +$138K | 0.05% | 183 |
|
|
2017
Q1 | $1.35M | Sell |
20,346
-3,991
| -16% | -$266K | 0.04% | 198 |
|
|
2016
Q4 | $1.59M | Buy |
24,337
+236
| +1% | +$15.3K | 0.05% | 171 |
|
|
2016
Q3 | $1.71M | Sell |
24,101
-2,638
| -10% | -$192K | 0.05% | 172 |
|
|
2016
Q2 | $1.98M | Sell |
26,739
-1,144
| -4% | -$79K | 0.07% | 163 |
|
|
2016
Q1 | $1.81M | Buy |
27,883
+57
| +0.2% | +$3.88K | 0.06% | 163 |
|
|
2015
Q4 | $2.15M | Buy |
27,826
+1,523
| +6% | +$121K | 0.08% | 155 |
|
|
2015
Q3 | $2.17M | Buy |
26,303
+1,807
| +7% | +$161K | 0.08% | 156 |
|
|
2015
Q2 | $2.16M | Buy |
24,496
+898
| +4% | +$82.4K | 0.07% | 150 |
|
|
2015
Q1 | $2.08M | Buy |
23,598
+983
| +4% | +$87.2K | 0.07% | 157 |
|
|
2014
Q4 | $1.88M | Buy |
22,615
+3,130
| +16% | +$259K | 0.06% | 164 |
|
|
2014
Q3 | $1.64M | Buy |
19,485
+9
| +0% | +$728 | 0.06% | 166 |
|
|
2014
Q2 | $1.58M | Sell |
19,476
-2,171
| -10% | -$171K | 0.06% | 155 |
|
|
2014
Q1 | $1.65M | Sell |
21,647
-396
| -2% | -$28.9K | 0.06% | 148 |
|
|
2013
Q4 | $1.59M | Sell |
22,043
-125
| -0.6% | -$8.69K | 0.06% | 152 |
|
|
2013
Q3 | $1.52M | Buy |
22,168
+2,793
| +14% | +$185K | 0.06% | 151 |
|
|
2013
Q2 | $1.23M | Buy |
+19,375
| New | +$1.26M | 0.05% | 159 |
|
Other funds holding NVS
Johnson Investment Counsel's NVS Position: Q2 2026 in Review
Johnson Investment Counsel increased its Novartis (NVS) stake by 0.67% in Q2 2026, buying an estimated $13K and bringing the position to 12,976 shares worth $2.03M. The position accounts for 0.01% of the portfolio, ranked #341.
Johnson Investment Counsel first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.26M in Q2 2025. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Johnson Investment Counsel held 12,976 shares of Novartis worth $2.03M as of Q2 2026.
- Johnson Investment Counsel bought 87 Novartis shares in Q2 2026, an estimated $13K.
- Novartis made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #341 holding.
- Johnson Investment Counsel first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Johnson Investment Counsel's Novartis position peaked at $2.26M in Q2 2025.
- 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.